BIOLIFE SOLUTIONS INC — Director's Dealing 2020

Nov 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-11-12

Reporting Person: Berard Todd (Chief Marketing Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-12	Common Stock	M	6000	$2.06	Acquired	69878	Direct
2020-11-12	Common Stock	S	6000	$32.46	Disposed	63878	Direct
2020-11-13	Common Stock	M	5000	$2.06	Acquired	68878	Direct
2020-11-13	Common Stock	S	5000	$32.16	Disposed	63878	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-12	Stock Option (Right to Buy)	$2.06	M	6000	Disposed	2025-05-04	Common Stock (6000)	Direct
2020-11-13	Stock Option (Right to Buy)	$2.06	M	5000	Disposed	2025-05-04	Common Stock (5000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.40 to $32.54, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.78 to $32.30, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: Exercisable to the extent of 1/4th thereof on 05/04/2016, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 06/04/2016.